Global DNA and Gene Chip Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
"Global DNA and Gene Chip Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global DNA and Gene Chip Market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global DNA and gene chip market report has been segmented on the type, application, end-use, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Gene chips are placed on glass substrate and have tiny cells that hold DNA probes. The cells are placed in arrays, which makes it possible to carry very large number of genetic tests on a given sample at a given time. They are used in pharmaceutical laboratories and in medical research to investigate the genes involved in disease processes and to speed up the process of discovering new drugs.
Rising demand for personalized diagnosis and treatment for cancer is a major factor driving growth of the global DNA and gene chip market. In addition, increasing government funding for genomics research is another factor propelling growth of the global market. Moreover, technological advancements in DNA microarrays so as to expand their application in biomedicine is a factor expected to create lucrative opportunities and support growth of the global market to a significant extent in the global market over the next 10 years.
Presence of alternate technology is a factor restraining growth of the global market to a certain extent currently. In addition, increasing demand for next generation sequencing is another factor hampering growth of the global market.
The North America market dominates the global DNA and Gene Chip Market in terms of revenue and is expected to maintain its dominance during the forecast period. Presence of major players, developed healthcare infrastructure, and increasing investments in research and development R&D activities in genomics are major factors driving growth of North America DNA and gene chip market. The Europe market accounts for significant share in terms of revenue in the global market. The Europe DNA and gene chip market is expected to witness moderate growth and is expected to register a CAGR of X.X% over the forecast period. The Asia Pacific DNA and gene chip market is expected to witness highest growth in terms of revenue in the global market and is projected to register a CAGR of XX.X% during the forecast period.
Global DNA and Gene Chip Market Segmentation:
Segmentation on the basis of type:
- Oligonucleotide DNA microarrays (oDNA)
- Complementary DNA microarrays (cDNA)
Segmentation on the basis of application:
- Cancer Diagnosis & Treatment
- Gene Expression
- Drug Discovery
- Agricultural Biotechnology
Segmentation on the basis of end-use:
- Academic & government research institutes
- Hospitals and diagnostics centres
- Biotechnology and pharmaceutical companies
Segmentation on the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- Thermo Fisher Scientific, Inc.
- Agilent Technologies
- Illumina, Inc.
- Perkin Elmer, Inc.
- Arrayit Corporation
- Macrogen Inc.
- Asper Biotech
- CapitalBio Corporation
- Greiner Bio One International GmbH
- Microarrays Inc.
- Oxford Gene Technology
- TOSHIBA HOKUTO ELECTRONICS CORPORATION
- Savyon Diagnostics
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!